Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petrochemical-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including water bottles, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products to manufacturers in the plastics industry. Danimer Scientific, Inc. was incorporated in 2004 and is headquartered in Bainbridge, Georgia.
IPO Year: 2020
Exchange: NYSE
Website: danimerscientific.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/13/2024 | $2.00 → $1.00 | Buy → Hold | TD Cowen |
5/22/2024 | $1.30 → $0.80 | Buy → Hold | Jefferies |
4/9/2024 | $3.50 → $1.25 | Overweight → Neutral | Piper Sandler |
10/12/2022 | $4.50 | Overweight | Piper Sandler |
9/23/2021 | $21.00 | Outperform | Cowen |
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
Dr. David Moody and Richard Altice to Join the Danimer Board Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the production of biodegradable materials, is pleased to announce that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer's Board of Directors. Dr. Moody's appointment is effective immediately, and Mr. Altice's appointment is effective as of April 15, 2024. Dr. David J. Moody currently is a member of the Board of Directors of Jadex Inc., a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the me
Martin, a Duke University graduate and former Air Force officer, brings experience managing the legal affairs of publicly traded companies Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Stephen Martin as Chief Legal Officer and Corporate Secretary. In this role, Martin will manage a wide range of legal matters across the company as Danimer continues to expand its manufacturing capacity to meet demand in the fast-growing bioplastics market. Martin joins Danimer from Kaman Distribution Group, a leading national distributor o
Austin brings more than 30 years of human resources leadership experience with PepsiCo, Delta Air Lines, Winn-Dixie and others Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Anthony Austin as Chief Human Resource Officer. In this role, Austin will focus on building best-in-class HR processes to strategically support the Company's growth as it continues to expand its manufacturing capacity. Austin joins Danimer from Bedrock Manufacturing Co., the parent company of Shinola, a luxury watch, leather and jewelry manufacturer an
Edwards brings technical expertise and business leadership built over a 30-year career with industry-leading polymer manufacturers including BASF and Chevron Phillips Chemical Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Keith A. Edwards as Vice President of Business Development. In this role, Edwards will focus on growing market opportunities for Danimer's biodegradable alternatives to traditional plastic as the Company continues to expand its manufacturing capacity. Edwards joins Danimer after nearly 18 years with BASF
Jad Dowdy to assume new role of Senior Vice President of Financial Planning and Analysis Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the appointment of Michael (Mike) A. Hajost as Chief Financial Officer. Hajost will succeed John A. (Jad) Dowdy, III, who will assume the new role of Senior Vice President, Financial Planning and Analysis. Hajost will join the Company on February 7, 2022, as special advisor to Danimer's Chief Executive Officer Stephen E. Croskrey before assuming the CFO position in early March 2022. Hajost most recently se
4 - Danimer Scientific, Inc. (0001779020) (Issuer)
PRE 14A - Danimer Scientific, Inc. (0001779020) (Filer)
424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
10-Q - Danimer Scientific, Inc. (0001779020) (Filer)
8-K - Danimer Scientific, Inc. (0001779020) (Filer)
424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
8-K - Danimer Scientific, Inc. (0001779020) (Filer)
8-A12G - Danimer Scientific, Inc. (0001779020) (Filer)
424B3 - Danimer Scientific, Inc. (0001779020) (Filer)
8-K - Danimer Scientific, Inc. (0001779020) (Filer)
DEFA14A - Danimer Scientific, Inc. (0001779020) (Filer)
TD Cowen downgraded Danimer Scientific from Buy to Hold and set a new price target of $1.00 from $2.00 previously
Jefferies downgraded Danimer Scientific from Buy to Hold and set a new price target of $0.80 from $1.30 previously
Piper Sandler downgraded Danimer Scientific from Overweight to Neutral and set a new price target of $1.25 from $3.50 previously
Piper Sandler initiated coverage of Danimer Scientific with a rating of Overweight and set a new price target of $4.50
Cowen initiated coverage of Danimer Scientific with a rating of Outperform and set a new price target of $21.00
Jefferies Financial Group reiterated coverage of Danimer Scientific with a rating of Buy and set a new price target of $66.00 from $49.00 previously
Eagle Beverage, a leading manufacturer of straws made from resins utilizing Nodax® brand polyhydroxyalkanoate (PHA), has announced the opening of its first PHA Injection Molding manufacturing plant. This groundbreaking facility marks a significant milestone in the company's mission to revolutionize the single-use cutlery industry with sustainable alternatives. Eagle Beverage is proud to announce the successful commercialization of Danimer Scientifc's proprietary resins made from Nodax PHA to manufacture single-use forks, knives, and spoons. Eagle Beverage has already begun shipping these innovative products to customers, demonstrating the immediate market readiness of its PHA-based cutlery
--Additional Resin Orders to Support 20-Million Pound Cutlery Award -- -- Company Forecasting Annualized PHA Revenues to More Than Triple by End of Q2 2025 -- -- Pro-Rata Warrant Dividend Transaction Provides Balance Sheet Deleveraging Opportunity -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its second quarter ended June 30, 2024. Stephen E. Croskrey, Chief Executive Officer of Danimer, commented, "We completed the second quarter in line with our expectations considering the temporary impact of Starbucks' r
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its second quarter 2024 financial results after the market closes on Thursday, August 8, 2024. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's second quarter results, discuss recent events and conduct a question and-answer session. The live webcast of the conference will be accessible on the Investor Relations section of the Company's website at https://ir.danimerscientific.com. For those unable to acce
Danimer Scientific, Inc. (NYSE:DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the completion of a previously announced pro-rata dividend distribution of warrants ("Dividend Warrants") to holders of the Company's Class A Common Stock, par value $0.0001 per share ("Common Stock"), as of May 13, 2024 ("Record Date"). The stockholders of record as of the Record Date received one (1) Dividend Warrant for every three (3) shares of Common Stock held as of the Record Date, subject to downward rounding. Holders of our 3.250% Convertible Senior Notes due 2026 ("Convertible N
The Company's common stock continues to trade on the NYSE under symbol "DNMR" Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the production of biodegradable materials, announced that it received a notice from the New York Stock Exchange ("NYSE") on May 21, 2024, that the Company is not currently in compliance with the NYSE's continued listing standard requiring listed-company stock to maintain an average closing price of not less than $1.00 per share over a period of thirty consecutive trading days ("Minimum Price Standard"). The Notice does not result in the immediate delisting of the Company's Common Stock fro
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that Stephen E. Croskrey has informed the Board of Directors that he will retire as Chief Executive Officer not later than the end of this calendar year. Mr. Croskrey's employment contract expires at the end of 2024 following nine years leading Danimer's mission to commercialize its innovative biodegradable plastic resin, Nodax® PHA. Mr. Croskrey has led Danimer through the process of becoming a public company by merging with Live Oak Acquisition Corp in 2020. During Mr. Croskrey's tenure, Danim
-- PHA Revenue Increase of 64% Year-Over-Year – -- First Commercial Order Received for 20-Million Pound Cutlery Award -- -- Previously Announced $20 Million Revolving Credit Facility Provides for Additional Liquidity – -- Previously Announced Proposed Pro-Rata Warrant Dividend Transaction -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its first quarter ended March 31, 2024. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, "We completed the first quarter in line with our expec
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of PHA biopolymers, is unveiling new commercial applications and branding during NPE 2024, North America's largest plastics tradeshow, taking place this week in Orlando, FL. A more perfect polymer™ takes center stage at NPE 2024. Danimer's signature PHA, Nodax®, represents a more perfect polymer revolution. PHAs (polyhydroxyalkanoates) are naturally made polymer chains, and at Danimer we harness microbes as tiny reactors to make our biopolymers, using canola oil as the renewable feedstock. The resulting PHA can be used to replace conven
Danimer Scientific, Inc. (NYSE:DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a proposed pro-rata dividend distribution of warrants ("Dividend Warrants") to holders of the Company's Class A Common Stock, par value $0.0001 per share ("Common Stock") as of May 13, 2024 ("Record Date"). Subject to the Company's stockholders approving a proposal to increase the authorized number of shares of the Company's Common Stock under the Company's Fourth Amended and Restated Certificate of Incorporation at the Company's upcoming annual meeting of stockholders to be held on or ab
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2024 financial results after the market closes on Tuesday May 7, 2024. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's first quarter results, discuss recent events and conduct a question and-answer session. The live webcast of the conference will be accessible on the Investor Relations section of the Company's website at https://ir.danimerscientific.com . For those unable to access the
SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)
SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)
SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)
SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)
SC 13G - Danimer Scientific, Inc. (0001779020) (Subject)
SC 13G - Danimer Scientific, Inc. (0001779020) (Subject)
SC 13D - Danimer Scientific, Inc. (0001779020) (Subject)
SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)
--Additional Resin Orders to Support 20-Million Pound Cutlery Award -- -- Company Forecasting Annualized PHA Revenues to More Than Triple by End of Q2 2025 -- -- Pro-Rata Warrant Dividend Transaction Provides Balance Sheet Deleveraging Opportunity -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its second quarter ended June 30, 2024. Stephen E. Croskrey, Chief Executive Officer of Danimer, commented, "We completed the second quarter in line with our expectations considering the temporary impact of Starbucks' r
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its second quarter 2024 financial results after the market closes on Thursday, August 8, 2024. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's second quarter results, discuss recent events and conduct a question and-answer session. The live webcast of the conference will be accessible on the Investor Relations section of the Company's website at https://ir.danimerscientific.com. For those unable to acce
Danimer Scientific, Inc. (NYSE:DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the completion of a previously announced pro-rata dividend distribution of warrants ("Dividend Warrants") to holders of the Company's Class A Common Stock, par value $0.0001 per share ("Common Stock"), as of May 13, 2024 ("Record Date"). The stockholders of record as of the Record Date received one (1) Dividend Warrant for every three (3) shares of Common Stock held as of the Record Date, subject to downward rounding. Holders of our 3.250% Convertible Senior Notes due 2026 ("Convertible N
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2024 financial results after the market closes on Tuesday May 7, 2024. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's first quarter results, discuss recent events and conduct a question and-answer session. The live webcast of the conference will be accessible on the Investor Relations section of the Company's website at https://ir.danimerscientific.com . For those unable to access the
-- Results In-Line with March 20 Preannouncement -- -- Issues FY24 Guidance with Expectation for Accelerating Sales Growth -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended December 31, 2023. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, "While 2023 was a challenging year for the Company, we are greatly encouraged by the successes we had and we believe we remain well ahead of the competition in both deep understanding of the biodegradable p
-- PHA Revenue Up 11% Year-Over-Year in Fourth Quarter of 2023 -- -- Previously Announced Cutlery Award Poised to Expand -- -- PHA Revenue Increase of Approximately 60% Year-Over-Year Expected in First Quarter 2024 -- -- Expects to Become Adjusted EBITDA Positive in Early 2025 -- -- Announces Date for Fourth Quarter and Full Year 2023 Earnings Call -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced preliminary results for its fourth quarter and full year, ended December 31, 2023. Stephen E. Croskrey, Chairman and Chief Executive O
-- PHA-Based Product Revenue Grows 58% vs. Prior Year -- -- Bid Awards Issued to Danimer Converter Partners for Nodax-Based Cutlery Require Approximately 20 million pounds of resin annually -- -- Reduced Guidance Reflects Changes in Customer Launches and Timing of First Shipments -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of highly engineered biodegradable materials, today announced financial results for its third quarter, ended September 30, 2023. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer, commented, "We are excited to announce that new busin
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its third quarter 2023 financial results after the market closes on Tuesday November 14, 2023. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's third quarter results, discuss recent events and conduct a question and-answer session. The live webcast of the conference will be accessible on the Investor Relations section of the Company's website at https://ir.danimerscientific.com. For those unable to acces
-- Issues Separate Release Announcing Accepted Part 2 Application for DoE Loan Guarantee -- -- Expands Portfolio with Resins for Protective Films, Shrink Wrap & Produce Bags -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of highly engineered biodegradable materials, today announced financial results for its second quarter, ended June 30, 2023. Danimer announced, in a separate release also issued after the close of market today, the acceptance of its Part II Application by the U.S. Department of Energy (DOE) under the Title XVII Loan Guarantee. The Company has been invited int
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its second quarter 2023 financial results after the market closes on Tuesday August 8, 2023. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's second quarter results, discuss recent events and conduct a question and answer session. The live webcast of the conference call can be accessed on the Investor Relations section of the Company's website at https://ir.danimerscientific.com. For those unable to acce
Jefferies analyst Laurence Alexander downgrades Danimer Scientific (NYSE:DNMR) from Buy to Hold and lowers the price target from $1.3 to $0.8.
Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that Stephen E. Croskrey has informed the Board of Directors that he will retire as Chief Executive Officer not later than the end of this calendar year. In connection with his retirement announcement, Mr. Croskrey has resigned from his position as Chairman of the Board, effective May 20, 2024, though he will continue to serve on the Board through his current term and will be a nominee for reelection at this year's annual meeting of stockholders. The Board has appointed Richard J. Hendrix as Chai
Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 27.78 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $10.224 million which missed the analyst consensus estimate of $11.063 million by 7.59 percent. This is a 14.27 percent decrease over sales of $11.926 million the same period last year.
Danimer Scientific, Inc. (NYSE:DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a proposed pro-rata dividend distribution of warrants ("Dividend Warrants") to holders of the Company's Class A Common Stock, par value $0.0001 per share ("Common Stock") as of May 13, 2024 ("Record Date"). Subject to the Company's stockholders approving a proposal to increase the authorized number of shares of the Company's Common Stock under the Company's Fourth Amended and Restated Certificate of Incorporation at the Company's upcoming annual meeting of stockholders to be held on or abo
The agreement, among other things, also allows for increases in the commitment up to an additional $5 million and matures on or about April 19, 2027 (earlier maturity is subject to occurrence of certain events).
Piper Sandler analyst Charles Neivert downgrades Danimer Scientific (NYSE:DNMR) from Overweight to Neutral and lowers the price target from $3.5 to $1.25.
TD Cowen analyst Thomas Boyes maintains Danimer Scientific (NYSE:DNMR) with a Buy and lowers the price target from $3 to $2.
Danimer Scientific (NYSE:DNMR) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Danimer Scientific missed estimated earnings by -3.0%, reporting an EPS of $-0.39 versus an estimate of $-0.38. Revenue was down $4.38 million from the same period last year. Past Earnings Performance Last quarter the company missed on EPS by $0.05 which was followed by a 10.0% drop in the share price the next day. Here's a look at Danimer Scientific's past performance: Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022 EPS Estimate -0.34 -0.36 -0.34 -0.29 EPS Actual -0.39 -0.38 -0.36 -0.28 Revenue Estimate 14.74M 13.90M